Groysbeck et al. [54] synthesized cetuximab, an anti-epidermal growth factor receptor (EGFR) mAb, and then conjugated it with gold nanoparticles to develop a targeted glioblastoma radiosensitizer (Au-Cmab). The gene discussed is EGFR; the disease is glioblastoma.